Harvard Bioscience And Etisense Announce Agreement For Supply And Distribution Of DECRO Miniature Telemetry Jacket Platform For Pre-Clinical Research
Portfolio Pulse from Benzinga Newsdesk
Harvard Bioscience, Inc. (NASDAQ:HBIO) and Etisense have entered into an agreement to offer DECRO, Etisense's non-invasive telemetry jacket and associated physiological monitoring software, to pre-clinical customers in the North American and European markets. Harvard Bioscience's Data Sciences International (DSI) pre-clinical business will serve as the exclusive distributor of Etisense's line of DECRO telemetry jackets and software in North America, the United Kingdom, and Ireland. The companies target first deliveries of the JET integration with Ponemah in the spring of 2024.
September 18, 2023 | 12:58 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Harvard Bioscience has entered into a partnership with Etisense to distribute DECRO telemetry jackets and software in North America, the UK, and Ireland. This could potentially increase the company's market reach and revenue.
The partnership with Etisense allows Harvard Bioscience to distribute a unique product in several key markets, which could lead to increased sales and revenue. The first deliveries are expected in spring 2024, indicating a potential positive impact on the company's performance in the medium term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100